Digital Therapeutic Based Randomized Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy: Rationale, Design, and Baseline Characteristics of the BRIGHT Trial

Digital Therapeutic Based Randomized Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy: Rationale, Design, and Baseline Characteristics of the BRIGHT Trial

Background The prevalence of type 2 diabetes continues to rise in the United States and worldwide. Although novel pharmacotherapies have shown benefits, not all patients have access to these medications and of those who do, some are unable to tolerate treatment. Behavior change is long known to be f...

Full description

Saved in:
Bibliographic Details
Main Authors: Mario Enrico Canonico, Judith Hsia, Frederick A. Masoudi, Hayden B. Bosworth, Stacy Greene, Bryan C. Batch, Natia Hamilton, Thiago B. de Araujo, Matthew Jackson, Marsha Broussard, Zonda Gooden, Nicole L. Guthrie, Bjorn Hansell, Laura Matteliano‐Madu, Kara Mosesso, Mark A. Berman, Marc P. Bonaca
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
AspyreRx
BT‐001
digital therapeutics
lifestyle management
type 2 diabetes
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.038737
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.124.038737

Similar Items